Chanelle Revenue and Competitors

Chanelle Pharma is Ireland's largest indigenous generic pharmaceutical manufacturer of both medical and veterinary products. \n \nServing customers in 96 countries worldwide, Chanelle Pharma is a partner of choice in the development and manufacturing of pharmaceutical products to the world’s leading human generic and animal health multinationals and distributors. We are passionate about understanding and addressing the challenges facing our medical and veterinary customers and bringing them innovative and effective products and solutions. \n \nBuilding on over 35 years of research and development, with over 4,500 licenses registered worldwide, Chanelle Pharma is headquartered on an 18 acre campus in Loughrea, Co Galway, with three manufacturing facilities, four research and development laboratories and a fifth R&D laboratory in Jordan. The company employs 550 people in Ireland, UK, Jordan and India. \n\nIn 2018, the company announced an €85 million investment, the single largest investment by any Irish owned company, to double manufacturing capacity, launch 96 new products and grow its workforce to 850 people over a period of 5 years. As part of the investment, Chanelle opened a purpose built €10 million manufacturing facility in 2018 to facilitate the company’s expansion plans in to the US market. The facility received FDA approval in September 2019. \n\nChanelle Pharma won 2018 Pharma Company of the Year and Industry Company of Year, the first indigenous Irish company to win the award.\n \nAt Chanelle Pharma, our employees drive our success. The company is on an ambitious growth trajectory and expanding its workforce across a number of disciplines in Science, Engineering, Quality, Finance, Sales and Marketing.\nYou will have the opportunity to collaborate in our diverse and inclusive environment, the ability to learn and grow in your career, and an opportunity to make a direct impact on our business and customers.